UPC
$2.40-0.06 (-2.52%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Recent News
Universe Pharmaceuticals Reports First Half 2025 Earnings
Universe Pharmaceuticals ( NASDAQ:UPC ) First Half 2025 Results Key Financial Results Revenue: US$9.15m (down 29% from...
Universe Pharmaceuticals Reports Full Year 2024 Earnings
Universe Pharmaceuticals ( NASDAQ:UPC ) Full Year 2024 Results Key Financial Results Revenue: US$23.0m (down 29% from...